Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine …
A Asatryan, N Meyer, M Scherbakov… - Human Vaccines & …, 2021 - Taylor & Francis
… In the study presented in this manuscript, we assessed the immunogenicity, reactogenicity,
… For interventional studies that evaluate our medicines, anonymized patient-level data and …
… For interventional studies that evaluate our medicines, anonymized patient-level data and …
[HTML][HTML] … safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen®) and tetanus, reduced-dose diphtheria …
L Fortuna, S Chaithongwongwatthana… - Vaccine, 2020 - Elsevier
… and 18% of adults presenting to hospital with prolonged cough … Each 0.5 mL single-dose
prefilled syringe of Pertagen and … Alignment of Immunization safety Assessment in pregnancy (…
prefilled syringe of Pertagen and … Alignment of Immunization safety Assessment in pregnancy (…
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children …
HJ Sharma, S Parekh, P Pujari, S Shewale… - Expert Review of …, 2023 - Taylor & Francis
… with reduced antigen content, acellular pertussis-containing … aspect of the thigh using a
23-gauge needle of 1-inch length. … in each Tdap vaccine group were presented for anti-TT, anti-…
23-gauge needle of 1-inch length. … in each Tdap vaccine group were presented for anti-TT, anti-…
Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines
P Pitisuttithum, J Dhitavat, C Sirivichayakul… - …, 2021 - thelancet.com
… formulation and combined with tetanus and reduced-dose diphtheria toxoids, was highly …
All study vaccines were presented as mono-dose prefilled syringes. 2.3 Assessment of …
All study vaccines were presented as mono-dose prefilled syringes. 2.3 Assessment of …
Low adenovirus vaccine doses administered to skin using microneedle patches induce better functional antibody immunogenicity as compared to systemic injection
O Flynn, K Dillane, JS Lanza, JM Marshall, J Jin… - Vaccines, 2021 - mdpi.com
… compared to injection with a needle and syringe in mice [12]. … DMNlo) induced significantly
reduced antigen-specific IgG2a … in each group prevents statistical analysis [6]. Repeated use …
reduced antigen-specific IgG2a … in each group prevents statistical analysis [6]. Repeated use …
Novel approaches to reactivate pertussis immunity
G Blanchard-Rohner - Expert Review of Vaccines, 2022 - Taylor & Francis
… , and was combined with tetanus and diphtheria toxoids (DTP … and evaluate new vaccines
against B. Pertussis [Citation38]. … suspension of 0.5 mL per dose in a pre-filled syringe (PFS). …
against B. Pertussis [Citation38]. … suspension of 0.5 mL per dose in a pre-filled syringe (PFS). …
Immunogenicity, safety, usability and acceptability of microarray patches for vaccination: a systematic review and meta-analysis
… in influenza MAPs compared with needle and syringe (N&S) (… for self or lay administration,
reduced antigen dose and no … , rubella, diphtheria, poliovirus, tetanus and rabies are still in …
reduced antigen dose and no … , rubella, diphtheria, poliovirus, tetanus and rabies are still in …
[PDF][PDF] Retracted: Highlights From the European Respiratory Society Congress 2023: Chronic Obstructive Pulmonary Disease and Severe Asthma
E Roberts - emjreviews.com
… that 75% of 1,025 patients evaluated would be eligible for biologic … Each 0.4 mL prefilled
syringe contains 40 mg of … 13), or reduced antigen diphtheriatetanus-acellular pertussis vaccine …
syringe contains 40 mg of … 13), or reduced antigen diphtheriatetanus-acellular pertussis vaccine …
Post-marketing surveillance of Tetravalent Diphtheria-Tetanus-Acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine in South Korea, 2009 to 2015
YJ Choe, E Vidor, C Manson - Infectious Diseases and Therapy, 2022 - Springer
… It has been evaluated for immunogenicity and safety in … in a single-dose prefilled syringe.
Each 0.5 mL dose of the … The demographic and baseline characteristics are presented in …
Each 0.5 mL dose of the … The demographic and baseline characteristics are presented in …
Key steps in vaccine development
PL Stern - Annals of Allergy, Asthma & Immunology, 2020 - Elsevier
… the program contents and evaluating recommendations. … of the protein carriers such as
tetanus or diphtheria toxoids. The B … Issues relating to the filling of vials or syringes, any storage …
tetanus or diphtheria toxoids. The B … Issues relating to the filling of vials or syringes, any storage …